Company news
Azitra Inc news in 2026
Azitra Inc's news releases, calls and decks from 2026, newest first.
Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors
October 29, 2026
Azitra, Inc. Announces Reverse Stock Split
October 16, 2026
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
August 21, 2026
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
August 12, 2026
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
June 17, 2026
Azitra, Inc. to Present at 2026 BIO International Convention
June 16, 2026
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
June 4, 2026
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
May 27, 2026
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
May 13, 2026
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program
May 6, 2026
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris
April 28, 2026
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million
March 19, 2026
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement
March 13, 2026
Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders
March 5, 2026
Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates
February 27, 2026
Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash
February 24, 2026
Azitra, Inc. to Present at BIO Investment & Growth Summit
February 19, 2026
Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
February 6, 2026
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
January 7, 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 30 slides · August 2026